Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01570153 · ClinicalTrials.gov registry record
Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT01570153: Completed study, sponsored by Massachusetts General Hospital.
NCT01570153 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01570153 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-11 |
What the finished NCT01570153 record still lists
NCT01570153 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01570153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01570153 about?
NCT01570153 is a clinical study titled "Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial". The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.
What is the current status of trial NCT01570153?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2012-03. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01570153?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia